You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 24, 2024

DEXRAZOXANE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Dexrazoxane Hydrochloride patents expire, and what generic alternatives are available?

Dexrazoxane Hydrochloride is a drug marketed by Eugia Pharma, Gland, and Hikma. and is included in three NDAs.

The generic ingredient in DEXRAZOXANE HYDROCHLORIDE is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dexrazoxane Hydrochloride

A generic version of DEXRAZOXANE HYDROCHLORIDE was approved as dexrazoxane hydrochloride by HIKMA on September 28th, 2004.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DEXRAZOXANE HYDROCHLORIDE?
  • What are the global sales for DEXRAZOXANE HYDROCHLORIDE?
  • What is Average Wholesale Price for DEXRAZOXANE HYDROCHLORIDE?
Drug patent expirations by year for DEXRAZOXANE HYDROCHLORIDE
Recent Clinical Trials for DEXRAZOXANE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ain Shams UniversityPhase 2/Phase 3
Maria Sklodowska-Curie National Research Institute of OncologyPhase 3
Polish Medical Research AgencyPhase 3

See all DEXRAZOXANE HYDROCHLORIDE clinical trials

Pharmacology for DEXRAZOXANE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DEXRAZOXANE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for DEXRAZOXANE HYDROCHLORIDE

US Patents and Regulatory Information for DEXRAZOXANE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eugia Pharma DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 200752-001 Oct 19, 2011 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 207321-001 Nov 28, 2016 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eugia Pharma DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 200752-002 Oct 19, 2011 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 207321-002 Dec 16, 2019 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 076068-002 Sep 28, 2004 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 076068-001 Sep 28, 2004 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.